Prestigious Prize Recognizes Pioneering Body's Defenses Discoveries

This year's Nobel Prize in medical science has been awarded for revolutionary findings that clarify how the immune system attacks harmful pathogens while sparing the body's own cells.

Three esteemed scientists—Japan's Shimon Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—share this honor.

Their research uncovered unique "sentinels" within the defense system that remove malfunctioning immune cells capable of harming the body.

The discoveries are now paving the way for new treatments for immune disorders and cancer.

These laureates will divide a prize fund valued at 11m SEK.

Crucial Discoveries

"The work has been decisive for comprehending how the body's defenses operates and why we do not all suffer from severe autoimmune diseases," stated the head of the award panel.

This team's studies address a fundamental mystery: In what way does the immune system defend us from countless invaders while leaving our own tissues intact?

Our body's protection system uses white blood cells that scan for signs of disease, including pathogens and bacteria it has never encountered.

These defenders utilize sensors—known as receptors—that are produced randomly in a vast number of combinations.

That provides the defense network the capacity to combat a broad range of invaders, but the unpredictability of the process unavoidably creates white blood cells that may target the body.

Security Guards of the Immune System

Researchers previously understood that a portion of these harmful defense cells were destroyed in the immune organ—where white blood cells develop.

This year's Nobel Prize recognizes the identification of T-reg cells—known as the body's "peacekeepers"—which travel through the body to disarm other defenders that assault the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The discoveries have laid the foundation for a novel area of investigation and accelerated the creation of new therapies, for instance for tumors and autoimmune diseases."

In malignancies, T-regs block the body from attacking the tumor, so studies are aimed at lowering their quantity.

In self-attack disorders, experiments are exploring increasing T-reg cells so the body is no longer under attack. A comparable method could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, from Osaka University, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that injecting immune cells from other mice could stop the illness—implying there was a system for preventing immune cells from harming the host.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in mice and people that led to the discovery of a gene critical for how T-regs operate.

"The pioneering work has revealed how the body's defenses is kept in check by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a leading physiology expert.

"The research is a remarkable illustration of how fundamental biological study can have far-reaching consequences for public health."